This site uses cookies to store information on your computer. Learn more x

Chinese FDA listing for DSM’s organic Alpine bioactives line ALPAFLOR®

Kaiseraugst, CH, 13 Oct 2014 12:00 CEST

DSM’s unique ALPAFLOR® Personal Care portfolio is now fully listed by the Chinese Food & Drug Administration (CFDA).
Edelweiss flower macro

The ALPAFLOR portfolio contains high performing organic bioactives and follows a truly organic philosophy from the seeds to the bioactive. Starting as a pioneer more than a decade ago, today DSM cultivates a wealth of plants and flowers at high altitude in the Swiss Alps according to the standards of Bio Suisse. They are produced at DSM’s own manufacturing site in Vouvry in the Swiss Valais. ALPAFLOR has become a globally accepted standard for organic, highly effective, ECOCERT, COSMOS and NATRUE certified bioactives from Swiss Alpine plants.

Last year DSM presented new exciting in vitro and in vivo findings on ALPAFLOR EDELWEISS, confirming skin comfort improvement and skin aging prevention. 3 out of 4 consumers with perceivable sensitive skin, reported a more comfortable skin feel after only 1 month care with a cream containing 3% ALPAFLOR EDELWEISS. The new listing in China and the worldwide ECOCERT, COSMOS, and NATRUE certifications make ALPAFLOR attractive for natural and organic formulations around the globe.

Marie-Sophie Meisinger, Global Marketing Manager Skin Care at DSM, comments: “High performance, organic cultivation and sustainability have always been the core values of ALPAFLOR. The full listing in China, one of the most important skin care markets globally, once again proves that ALPAFLOR is a strong partner worldwide in the field of natural beauty”.